Search results for "INTERFERON-GAMMA"

showing 10 items of 352 documents

Serum VEGF and b-FGF profiles after tension-free or conventional hernioplasty.

2005

Angiogenesis is strongly influenced by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF), whose production is also regulated by interferon (IFN)-gamma and interleukin (IL)-10. The aim of this study was to evaluate the modifications of serum VEGF, b-FGF, IFN-gamma and IL-10 levels in patients with inguinal hernia undergoing hernioplasty with the Lichtenstein technique (LH) using polypropylene mesh or with Bassini open conventional inguinal hernia repair (BH). MATERIALS AND METHODS: Randomly, 16 patients underwent BH, and 16 were treated with the LH technique using polypropylene mesh. Blood samples were collected 24 h prior to surgery and then 6, 24, 48 and …

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisBasic fibroblast growth factorUrologyEnzyme-Linked Immunosorbent AssayHernia InguinalStatistics Nonparametricchemistry.chemical_compoundInterferon-gammaMedicineHumansIFN-γMeshAnalysis of Variancebusiness.industryInterleukinMiddle AgedSurgical Meshmedicine.diseaseVEGFSurgeryInterleukin-10Vascular endothelial growth factorInterleukin 10Inguinal herniachemistryHernioplastyIL-10SurgeryCytokine secretionFibroblast Growth Factor 2b-FGFbusinessAbdominal surgery
researchProduct

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

2006

INTRODUCTION Angiogenesis has been correlated with increased invasion and metastases in a variety of human neoplasms. Inadequate inhibition of the growth of tumor microvessels by anticancer agents may result in treatment failure, rated clinically as progressive or stable disease. We designed this trial to investigate the modification of the vascular endothelial growth factor (VEGF) and interferon-gamma (IFN-gamma) in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. MATERIALS AND METHODS Forty-five metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF and IFN-gamma during the treatment wit…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanGastroenterologyNeovascularizationInterferon-gammaBasal (phylogenetics)chemistry.chemical_compoundangiogenesis cetuximab colorectal cancer irinotecanInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyAgedNeovascularization PathologicCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseVascular endothelial growth factorIrinotecanTreatment OutcomeEndocrinologyOncologychemistryCamptothecinFemalemedicine.symptomColorectal Neoplasmsbusinessmedicine.drug
researchProduct

Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis

1992

The pathogenetic mechanisms underlying the development of reactive arthritis and the functional capacities of synovial T cells specific for Yersinia enterocolitica are still unclear. In this study we have determined the cytokine secretion patterns of 24 CD4+ synovial fluid (SF)-derived T cell clones from 2 patients with Yersinia-induced reactive arthritis, 16 clones specific for different Yersinia antigens and 8 clones as controls. The clones specific for Yersinia antigens predominantly belong to the T helper cell 1 (Th1) subset with production of interferon (IFN)-gamma and interleukin (IL)-2, but no IL-4, whereas SF T cells not reactive with Yersinia antigens produce IL-2, IL-4 and IFN-gam…

AdultMaleYersinia Infectionsmedicine.medical_treatmentT cellImmunologyYersiniaLymphocyte ActivationArthritis ReactiveMicrobiologyInterferon-gammaImmune systemAntigenSynovial FluidmedicineHumansImmunology and AllergyYersinia enterocoliticaYersinia enterocoliticabiologyT-Lymphocytes Helper-InducerT helper cellbiology.organism_classificationmedicine.anatomical_structureCytokineImmunologyInterleukin-2Cytokine secretionInterleukin-4
researchProduct

Static magnetic fields generated by a 0.5T MRI unit affects in vitro expression of activation markers and interleukin release in human peripheral blo…

2001

To investigate the effects of the static magnetic field (SMF) generated by a 0.5 T superconducting MRI unit on in vitro activation marker expression and interleukin release in human peripheral blood mononuclear cell (PBMC) samples from healthy volunteers.PBMC samples were split into two groups: exposed and sham-exposed under isothermal conditions. PBMC were exposed for 2 h at 24 degrees C to the SMF of a 0.5 T superconducting MRI unit. Immediately after exposure, both samples were cultured for 24 h at 37 degrees C with or without mitogenic stimulation by phytohaemagglutinin (PHA). PBMC were examined for expression of CD25, CD69 and CD71 by immunofluorescence analysis and supernatants were a…

AdultMalechemical and pharmacologic phenomenaBiologyLymphocyte ActivationImmunofluorescencePeripheral blood mononuclear cellBlood cellInterferon-gammaMagneticsAntigens CDmedicineHumansRadiology Nuclear Medicine and imagingIL-2 receptorPhytohemagglutininsCells CulturedPhytohaemagglutininRadiological and Ultrasound Technologymedicine.diagnostic_testCD69Interleukinhemic and immune systemsMagnetic Resonance ImagingMolecular biologyStimulation ChemicalIn vitromedicine.anatomical_structureImmunologyLeukocytes Mononuclearbiology.proteinFemaleInterleukin-4BiomarkersInternational Journal of Radiation Biology
researchProduct

Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML …

1990

Alpha- and gamma-interferons have been shown to actively suppress hematopoiesis in patients in the chronic phase of chronic myelogenous leukemia in vitro and in vivo. Since both interferons act through different receptors on their hematopoietic target cells, they are expected to be capable of independently inhibiting abnormal blood cell development in patients with chronic myelogenous leukemia. We have utilized recombinant human interferon alfa-2c to treate 11 patients with Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase, who were resistant to previous interferon gamma therapy. Ten of the patients were evaluable for hematologic, cytogenetic and molecular-genet…

AdultMalemedicine.medical_specialtyDrug ResistanceAlpha interferonBiologyCytogeneticsInterferon-gammaInterferonhemic and lymphatic diseasesInternal medicineLeukemia Myelogenous Chronic BCR-ABL PositivemedicineHumansInterferon gammaInterferon alfaHematologybreakpoint cluster regionHematologyGeneral MedicineMiddle Agedmedicine.diseaseHematologic ResponseRecombinant ProteinsImmunologyInterferon Type ICancer researchDrug EvaluationFemalemedicine.drugChronic myelogenous leukemiaBlut
researchProduct

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response

2009

Abstract Background Interferon-gamma (IFN-γ) release assays (IGRAs) were designed to detect latent tuberculosis infection (LTBI). However, discrepancies were found between the tuberculin skin test (TST) and IGRAs results that cannot be attributed to prior Bacille Calmètte Guerin vaccinations. The aim of this study was to evaluate tools for improving LTBI diagnosis by analyzing the IFN-γ response to RD1 proteins in prolonged (long-term response) whole blood tests in those subjects resulting negative to assays such as QuantiFERON-TB Gold In tube (QFT-IT). Methods The study population included 106 healthy TST+ individuals with suspected LTBI (recent contact of smear-positive TB and homeless) c…

AdultMalemedicine.medical_specialtyTuberculosisTuberculinlcsh:Infectious and parasitic diseasesMycobacterium tuberculosisInterferon-gammaYoung AdultMedical microbiologyAntigenLatent TuberculosismedicineHumanslcsh:RC109-216tuberculosis latent infection IGRA testAntigens BacterialLatent tuberculosisbiologyTuberculin Testbusiness.industryMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationbacterial infections and mycosesVaccinationLong term responseInfectious DiseasesImmunologyFemaleReagent Kits DiagnosticbusinessResearch ArticleBMC Infectious Diseases
researchProduct

Effects of metformin on autoimmune immunoglobins and interferon-γ in patients with early diagnosed pemphigus vulgaris: a prospective clinical trial.

2021

The management of pemphigus vulgaris (PV) is challenging. This study aimed to evaluate the immunomodulating effects of metformin on PV. The study was conducted in two phases: in the first phase, patients received routine first-line treatment (prednisolone plus azathioprine) for 2 months, then in the second phase, metformin was added to this regimen for another 2 months. After addition of metformin to the first-line medications, significant reductions were seen in serum IgG1 (reduced from 534.92 ± 134.83 mg/dL to 481.58 ± 130.46 mg/dL, P < 0.001), IgG4 (51.83 ± 27.26 mg/dL to 44.50 ± 26.05 mg/dL, P < 0.001) and interferon-γ (277.99 ± 108.71 pg/mL to 45.05 ± 17.080 pg/mL, P = 0.03) concentrat…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAzathioprineDermatologyGastroenterologySubclassSteroidInterferon-gammaInternal medicinemedicineHumansProspective Studiesbusiness.industryPemphigus vulgarisMiddle Agedmedicine.diseaseMetforminMetforminClinical trialRegimenImmunoglobulin GPrednisoloneFemalebusinessPemphigusmedicine.drugClinical and experimental dermatologyReferences
researchProduct

Cytokine modifications after tension-free hernioplasty or open conventional inguinal hernia repair

2001

Abstract Background: The purpose of this study was to evaluate the involvement of proinflammatory cytokines (interferon-γ [INF-γ], interleukin [IL]-6) and anti-inflammatory cytokines (IL-4, IL-l0, IL-13) in patients undergoing Lichtenstein tension-free hernioplasty (LH) using polypropylene prosthetic materials or conventional Bassini hernia (BH) repair. Methods: Thirty-five male patients (age range 25 to 60 years) with unilateral inguinal hernia without complications or recurrence were included in this study. Randomly, patients underwent conventional operation and had their inguinal hernia repair performed with polypropylene mesh. Peripheral venous blood samples were collected 24 hours prio…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyHernia InguinalPolypropylenesPeripheral blood mononuclear cellProinflammatory cytokineInterferon-gammaBlood plasmamedicineHumansHerniaAnalysis of Variancebusiness.industryInterleukinsInterleukinGeneral MedicineMiddle AgedSurgical Meshmedicine.diseaseSurgeryInguinal herniaCytokineSurgical meshSurgerybusinessThe American Journal of Surgery
researchProduct

Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis.

1993

SUMMARY The pathogenic mechanisms underlying the development of autoimmune hepatitis (AIH) are still unclear. Since AIH is associated with the presence of various autoantibodics and certain HLA subtypes, it is likely that T and B cells play a major role in this disease. In this study we have determined the functional capacities of in vivo preactivated liver-infiltrating T cells (LTC) from patients with AIH. As controls we used LTC from patients with non-autoimmune hepatitis (non-AIH). Our results show that preactivated LTC from patients with AIH predominantly (190/255 clones) reside in the CD4+ population, whereas LTC in non-AIH are dominated by the CD8+ phenotype (148/254 clones). In view …

AdultMalemedicine.medical_treatmentT cellCD8 AntigensT-LymphocytesImmunologyPopulationAutoimmune hepatitisHuman leukocyte antigenBiologyAutoimmune DiseasesHepatitisInterferon-gammaImmune systemimmune system diseasesmedicineImmunology and AllergyHumanseducationeducation.field_of_studyTumor Necrosis Factor-alphaInterleukinsMiddle Agedmedicine.diseasedigestive system diseasesClone CellsCytokinemedicine.anatomical_structureLiverImmunologyCD4 AntigensCytokinesCytokine secretionFemaleCD8Research ArticleClinical and experimental immunology
researchProduct

HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis

1997

Objective.To study whether peptides derived from the HLA-B27 molecule sequence can stimulate peripheral blood T lymphocytes (PBL) from patients with HLA-B27-associated spondylarthropathies. Methods.PBL from 55 HLA-B27+ patients with ankylosing spondylitis (AS), 28 HLA-B27+ patients with other spondylarthropathies, 7 rheumatoid arthritis patients, and 30 HLA-B27+ and 22 HLA-B27- healthy controls were tested in lymphocyte proliferation assays with 4 synthetic peptides derived from the HLA-B*2705 molecule. Results. A 13-mer peptide (B27PA) induced significant proliferative responses in 17 of the 55 AS patients (stimulation index [SI] 2.5–17.5), as well as in 3 of the HLA-B27+ healthy controls …

AdultMalemusculoskeletal diseasesAdolescentT-LymphocytesT cellImmunologyEnzyme-Linked Immunosorbent AssayLymphocyte proliferationLymphocyte ActivationMajor histocompatibility complexAutoantigensCell LineInterferon-gammaRheumatologyAntigenHumansImmunology and AllergyMedicineSpondylitis AnkylosingPharmacology (medical)SpondylarthropathiesHLA-B27 AntigenAgedHLA-B27biologybusiness.industryT-cell receptorReceptors Antigen T-Cell gamma-deltaT lymphocyteMiddle AgedFlow CytometryPhenotypemedicine.anatomical_structureImmunologybiology.proteinFemalePeptidesbusinessArthritis &amp; Rheumatism
researchProduct